Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$614.20
+0.45%
Mkt Cap $65.47B
Analyst Ratings
Buy
20
Hold
6
Sell
0
Price Target (115 analysts)
$862.74
Range $700.00 – $1,057.00
Implied Upside
+40.5%
Consensus $862.74 vs current $614.20